India confirmed the first death from an adverse reaction to the COVID-19 vaccine, the only one confirmed so far by Indian authorities after more than 250 million doses administered in nearly five months.
A 68-year-old man died of anaphylaxis after receiving a dose of Covishield from AstraZeneca on March 8, manufactured by the Serum Institute of India (SII), the National Committee for Adverse Events after Immunization (AEFI) details in a report. ) of the Indian Ministry of Health.
Death, classified as a vaccine-related reaction, is one of the three events that has been directly attributed to anticovid inoculation out of more than 30 investigated cases, the majority of which occurred shortly after vaccination.
“This is the first death in which causality has been established with the vaccine resulting in an anaphylaxis reaction. But compared to the overall figures, only a small number had a serious reaction,” said the AEFI National Committee advisor, NK Arora, in statements released by local media.
Two other events of anaphylaxis due to the vaccine were confirmed in a 22-year-old man and a 21-year-old woman, after receiving a dose of the indigenous formula Covaxin, from the Indian laboratory Bharat Biotech, and a dose of Covishield, respectively.
“Of the 31 cases evaluated, 18 were classified as having an inconsistent causal association with vaccination (coincident-not related to vaccination), 7 were classified as indeterminate, while 3 cases were related to the vaccine product,” he explained. .
The Asian country has reported 2.7 deaths per million doses of vaccine administered and 4.8 hospitalizations per million doses of vaccine administered, however, clarified the authority, “the mere notification of deaths and hospitalizations as serious adverse events does not imply automatically that the events were caused by vaccines. “
India has administered 256 million vaccines since last January, 225 million of them from Covishield, and 31 million from Covaxin.
The Indian Health Ministry said in a statement that the number of deaths reported after vaccination in the country is only 0.0002% of the administered doses, which is within the expected death rates in a population, he said.